— Know what they know.
Not Investment Advice
Also trades as: RAD.AX (ASX) · $vol 0M

RADX NASDAQ

Radiopharm Theranostics Limited
1W: -12.1% 1M: -32.9% 3M: -66.7% YTD: -71.9% 1Y: -74.7%
$1.42
-0.06 (-4.05%)
 
Weekly Expected Move ±15.7%
$1 $1 $1 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $1.8M mcap · 819522 float · 7.90% daily turnover · Short 60% of daily vol

Balance Sheet Trends

Total Assets
$86M +20.1% ▲
3Y CAGR: +1.2%
Total Liabilities
$44M -2.4% ▼
3Y CAGR: +28.8%
Shareholders Equity
$45M +59.3% ▲
3Y CAGR: -10.7%
Cash & Investments
$29M +56.8% ▲
3Y CAGR: +2.6%
Total Debt
$0 +0.0% ▲
Net Debt
-$29M -56.8% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024
— Assets —
Cash$27M$12M$19M$29M
Short-Term Investments$0$0$0$0
Cash & ST Investments$27M$12M$19M$29M
Net Receivables$56K$4M$987K$10M
Inventory$0$0$0$0
Other Current Assets$229K$133K$3M$337K
Total Current Assets$27M$16M$23M$40M
Property, Plant & Equip.$2K$68K$61K$53K
Goodwill & Intangibles$56M$59M$49M$47M
Long-Term Investments$0$0$40K$0
Other Non-Current Assets$40K$40K$0$0
Total Non-Current Assets$56M$59M$49M$47M
Total Assets$83M$75M$72M$86M
— Liabilities —
Accounts Payable$1M$3M$6M$6M
Short-Term Debt$0$0$0$0
Deferred Revenue$0$0$0$2M
Other Current Liabilities$6M$8M$7M$4M
Total Current Liabilities$8M$13M$18M$15M
Long-Term Debt$0$0$0$0
Other Non-Current Liab.$13M$16M$27M$29M
Total Non-Current Liabilities$13M$16M$27M$29M
Total Liabilities$20M$29M$45M$44M
— Equity —
Common Stock$87M$97M$101M$177M
Retained Earnings-$31M-$65M-$111M-$146M
Accumulated OCI$7M$10M$38M$13M
Total Stockholders Equity$63M$44M$28M$45M
Total Liabilities & Equity$83M$75M$72M$86M
— Key Metrics —
Total Debt$0$0$0$0
Net Debt-$27M-$12M-$19M-$29M
Total Investments$0$0$40K$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms